secwatch.observer — SEC 8-K summary
======================================

Issuer:     Renalytix plc (RNLXY)
CIK:        0001811115
Form:       8-K
Filed at:   2024-06-24T23:59:59+00:00
Accession:  0000950170-24-076884
Event type: regulatory
Sentiment:  negative
Materiality: 1.00
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Renalytix receives Nasdaq delisting notice; intends to appeal by June 28
------------------------------------------------------------------------

- Nasdaq determined company did not regain compliance with minimum bid price ($1.00) and MVLS ($50M) by June 19, 2024.
- Unless appeal is filed by June 28, ADS trading will be suspended at opening on July 2, 2024, and Form 25-NSE filed.
- Company intends to request a hearing before Nasdaq Hearings Panel, which will stay suspension pending decision.
- Plan to present a strategic plan to regain compliance; no assurance of acceptance or success.
- Delisting could impair liquidity, accurate quotations, and ability to raise capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811115/000095017024076884/0000950170-24-076884-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811115/000095017024076884/rnlx-20240621.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-076884

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer